About
Contact & Profiles
A5056844521
Research Areas
- Streptococcal Infections and Treatments
- Infective Endocarditis Diagnosis and Management
- Genital Health and Disease
- Urinary Bladder and Prostate Research
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- Toxin Mechanisms and Immunotoxins
- Sexual function and dysfunction studies
- COVID-19 Clinical Research Studies
Beth Israel Deaconess Medical Center
2024
Harvard University
2024
Current COVID-19 vaccines provide robust protection against severe disease but minimal acquisition of infection. Intramuscularly administered induce serum neutralizing antibodies (NAbs), their ability to boost mucosal immune responses remains be determined. In this study, we show that the XBB.1.5 messenger RNA (mRNA) boosters result in increased neutralization multiple acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants humans, including dominant circulating variant JN.1....
10.1126/scitranslmed.adp8920
article
EN
Science Translational Medicine
2024-10-23
Coming Soon ...